Evidence map›Paper›PMID 29980175›Full record

ArticleBMC infectious diseases2018

Late-onset paradoxical reactions 10 years after treatment for tuberculous meningitis in an HIV-negative patient: a case report.

Akira Machida, Tasuku Ishihara, Eiichiro Amano, Shinichi Otsu

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Akira MachidaDepartment of Neurology, Tsuchiura Kyodo General Hospital, 4-1-1Otsuno, Tsuchiura-shi, Ibaraki, 300-0028, Japan. akinuro@tmd.ac.jp.ORCID 0000-0001-7457-8866
Tasuku IshiharaDepartment of Neurology, Tsuchiura Kyodo General Hospital, 4-1-1Otsuno, Tsuchiura-shi, Ibaraki, 300-0028, Japan.
Eiichiro AmanoDepartment of Neurology, Tsuchiura Kyodo General Hospital, 4-1-1Otsuno, Tsuchiura-shi, Ibaraki, 300-0028, Japan.
Shinichi OtsuDepartment of Neurology, Tsuchiura Kyodo General Hospital, 4-1-1Otsuno, Tsuchiura-shi, Ibaraki, 300-0028, Japan.
Tsuchiura Kyodo General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough paradoxical reactions (PRs) to anti-tuberculosis (anti-TB) therapy during treatment are well-established occurrences, PRs presenting as a new lesion after the completion of treatment are extremely rare, and little is known about the management of such cases, particularly of central nervous system (CNS) tuberculosis. CASE PRESENTATION: A 27-year-old female, with a past medical history of tuberculous meningitis 10 years ago and who completed the anti-TB treatment with asymptomatic remnant tuberculomas in the basal cistern, was admitted to our hospital because of a headache and the worsening of pre-existing visual disturbance. Contrast-enhanced T1-weighted brain magnetic resonance imaging (MRI) revealed new tuberculomas in the left sylvian fissure with a diffuse low signal around it. Because repeated polymerase chain reaction and Mycobacterium tuberculosis culture presented negative results and the patient had no laboratory data suggestive of a relapse of tuberculous meningitis, she was diagnosed with late-onset post-treatment PRs and treated with oral corticosteroids, tapered off over 1 year. Eventually, the symptoms were relieved, and the tuberculomas disappeared.

conclusionsClinicians should consider the possibility of PRs long after the completion of tuberculous meningitis treatment. Hence, a precise MRI-based examination is imperative for the follow-up of CNS tuberculosis, and the unnecessary administration of anti-TB drugs should be avoided. The use of corticosteroids as a treatment option for post-treatment PRs is seemingly safe when the isolated M. tuberculosis is sensitive to the first-line anti-TB therapy.

Indexed as

Administration, OralAdrenal Cortex HormonesAdultAntitubercular AgentsBrainFemaleHeadacheHIV SeronegativityHumansMagnetic Resonance ImagingMycobacterium tuberculosisPolymerase Chain ReactionPrednisoloneTuberculomaTuberculosis, MeningealAdrenal Cortex HormonesAntitubercular AgentsPrednisoloneParadoxical reactionsTuberculomaTuberculous meningitis

Identifiers

PMID29980175
PMCPMC6035426
OpenAlexW2848847477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.